MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04167nam a22004815i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231109085847.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220101s2022 sz | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783030827908 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1007/978-3-030-82790-8 |
| Source of number or code |
doi |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
TR-AnTOB |
| Language of cataloging |
eng |
| Transcribing agency |
TR-AnTOB |
| Description conventions |
rda |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 738 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MJN |
| Source |
bicssc |
|
|---|
| Subject category code |
MED056000 |
| Source |
bisacsh |
|
|---|
| Subject category code |
MKJ |
| Source |
thema |
| 096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
|---|
| Classification number |
QV738EBK |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
İngilizce |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Patsalos, Philip N. |
| Relator term |
author. |
| Relator code |
aut |
| -- |
http://id.loc.gov/vocabulary/relators/aut |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Antiseizure Medication Interactions |
| Medium |
[electronic resource] : |
| Remainder of title |
A Clinical Guide / |
| Statement of responsibility, etc. |
by Philip N. Patsalos. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
4th ed. 2022. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Cham : |
| Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
| -- |
Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section 1 – Introduction -- Section 2 – Drug Interactions Between AEDs -- Acetazolamide -- Cannabidiol -- Carbamazepine -- Clobazam -- Clonazepam -- Ethosuximide -- Eslicarbazepine acetate -- Felbamate -- Fenfluramine -- Gabapentin -- Lacosamide -- Lamotrigine -- Levetiraceta -- Methsuximide -- Oxcarbazepine -- Perampanel -- Phenobarbital -- Phenytoin -- Piracetam -- Pregabalin -- Primidone -- Rufinamide -- Stiripentol -- Tiagabine -- Topiramate -- Valproic Acid -- Vigabatrin -- Zonisamide -- Section 3 – Drug Interactions between AEDs and non-AED drugs: Interactions Affecting AEDs -- Acetazolamide -- Cannabidiol -- Carbamazepine -- Clobazam -- Clonazepam -- Ethosuximide -- Eslicarbazepine acetate -- Felbamate -- Fenfluramine -- Gabapentin -- Lacosamide -- Lamotrigine -- Levetiracetam -- Methsuximide -- Oxcarbazepine -- Perampanel -- Phenobarbital -- Phenytoin -- Piracetam -- Pregabalin -- Primidone -- Rufinamide -- Stiripentol -- Tiagabine -- Topiramate -- Valproic Acid -- Vigabatrin -- Zonisamide -- Section 4 – Drug Interactions between AEDs and non-AED drugs: Interactions Affected by AEDS -- Analgesics -- Antimicrobials -- Antineoplastic agents -- Antiulcer drugs -- Cardiovascular drugs -- Immunosuppressants -- Neuromuscular Blocking Agents -- Psychotropic Drugs -- Steroids -- Miscellanea. . |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
This significantly revised fourth edition provides a practically orientated guide to interactions associated with antiseizure medications. It describes pharmacokinetic and pharmacodynamic antiseizure medication (ASM) interactions, including details of the magnitude and mechanism of interactions, and also of drug combinations that are not associated with interactions and therefore can be co-prescribed without undue concern. Presented in alphabetical order and by drug class, drug interactions that occur between ASMs and also between ASMs and non- ASMs are described in three sections: Drug interactions between ASMs; Drug interactions between ASMs and non- ASM Drugs: Interactions affecting ASMs; Drug interactions between ASMs and non ASM Drugs: Interactions affected by ASMs. The latest data on all drug interactions is presented. New agents discussed include cannabidiol, cenobamate, everolimus and fenfluramine,. Antiseizure Medication Interactions: A Clinical Guide, 4th Edition concisely presents the most recent developments and data available on the topic. Therefore, enabling physicians and allied health professionals to make more rational choices when ASM polytherapy regimens are required. It will be of interest to medical professionals in disciplines including neurology, psychiatry and pediatrics. . |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Neurology . |
|
|---|
| Topical term or geographic name entry element |
Pharmacology. |
|
|---|
| Topical term or geographic name entry element |
Psychiatry. |
|
|---|
| Topical term or geographic name entry element |
Neurology. |
|
|---|
| Topical term or geographic name entry element |
Pharmacology. |
|
|---|
| Topical term or geographic name entry element |
Psychiatry. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-82790-8">https://doi.org/10.1007/978-3-030-82790-8</a> |
| Materials specified |
Springer eBooks |
| Public note |
Online access link to the resource |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
National Library of Medicine |
| Koha item type |
E-Book |
